Code | 03132 | ||||||||||
MA number | 48/0089/21-S | ||||||||||
Product Form: | sol inj 1x15 ml (liek.inj.skl.) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Mutual recognition procedure | ||||||||||
MAH, country: | Bayer AG, Germany | ||||||||||
Therapeutic Class: | 48 - DIAGNOSTICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - known active substance |
MA issued: | 30.03.2021 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
Pediatric warnings: | Yes |
PIL: |
|
SPC: |
|
Safety feature | No |
Data update: | 15.10.2021 |